Advancing inclusive research calculator for oncology disease areas: A resource to support the development of enrollment targets in diversity action plans for industry sponsors

The AIR Calculator serves as a valuable resource for planning of clinical studies, but additional data analyses are necessary for a comprehensive understanding at the study level. Comprehensive data collection and alignment across industry are essential to ensure consistent, accurate, and transparent benchmarks in historically underrepresented patient populations and to track progress toward the goal of improving their representation in clinical research.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2024-12-19
DOI
https://doi.org/10.1371/journal.pone.0315283
Citations
2
Primary Topic
Economic and Financial Impacts of Cancer
Type
article
Field-Weighted Citation Impact
2.26

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Advancing inclusive research calculator for oncology disease areas: A resource to support the development of enrollment targets in diversity action plans for industry sponsors

Nicole Richie, David J. Press, Spencer L James, Bruno Jolain
2 citations
PLoS ONE
Economic and Financial Impacts of Cancer
2.26
article

Advancing inclusive research calculator for oncology disease areas: A resource to support the development of enrollment targets in diversity action plans for industry sponsors

Nicole Richie, David J. Press, Spencer L James, Bruno Jolain
article en
2 citations

Abstract

The AIR Calculator serves as a valuable resource for planning of clinical studies, but additional data analyses are necessary for a comprehensive understanding at the study level. Comprehensive data collection and alignment across industry are essential to ensure consistent, accurate, and transparent benchmarks in historically underrepresented patient populations and to track progress toward the goal of improving their representation in clinical research.

PLoS ONEVol. 19(12)
Roche (Switzerland) (CH), Roche (United States) (US), Duke University (US)
Genentech
Partnerships for the goals
Openalex Percentile: Top 7%
Economic and Financial Impacts of Cancer
2.26
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.